TY - JOUR
T1 - Hypertension healthcare professional beliefs and behaviour regarding patient medication adherence
T2 - a survey conducted among European Society of Hypertension Centres of Excellence
AU - Burnier, Michel
AU - Prejbisz, Aleksander
AU - on behalf of the Working Group on Cardiovascular Therapy and Adherence of the European Society of Hypertension
AU - Weber, Thomas
AU - Azizi, Michel
AU - Cunha, Vitoria
AU - Versmissen, Jorie
AU - Gupta, Pankaj
AU - Vaclavik, Jan
AU - Januszewicz, Andrzej
AU - Persu, Alexandre
AU - Kreutz, Reinhold
N1 - Funding Information:
This project was financially supported by a grant from the Foundation of the European Society of Hypertension.
Publisher Copyright: © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2021/8/14
Y1 - 2021/8/14
N2 - Purpose: Little is known on the beliefs, perceptions and practices of hypertension specialists in addressing non-adherence to therapy. Therefore, a survey was undertaken amongst healthcare professionals (HCPs) managing hypertension in the European Society of Hypertension (ESH) Centres of Excellence. Materials and methods: Cross-sectional data were obtained between December 2020 and April 2021 using an online anonymous structured questionnaire including 26 questions/136 items, that was sent to all ESH Excellence centres. Results: Overall 67 from 187 centres (37.3%) responded and 200 HCPs from 30 countries answered the questionnaire. Participants (60% men) were mainly physicians (91%) and nurses (8%) from University hospitals (77%). Among physicians, 83% had >10 years professional experience. Average time dedicated to discuss medications was 1-5 min in 48% and 6-10 min in 29% of cases. Interviews with patients about adherence were the most frequently used assessment method. Chemical detection of medications in urine was available in 36% of centres. One third of physicians involved their patients regularly in treatment decisions. The most frequent methods to improve adherence included simplification of medication therapy, more frequent visits, and home blood pressure monitoring. Conclusions: The level of implementation of tools to detect and improve adherence in hypertension management by HCPs in ESH excellence centres is low. Structured educational activities focussing on adherence management and access to the newest objective measures to detect non-adherence might improve these deficits.
AB - Purpose: Little is known on the beliefs, perceptions and practices of hypertension specialists in addressing non-adherence to therapy. Therefore, a survey was undertaken amongst healthcare professionals (HCPs) managing hypertension in the European Society of Hypertension (ESH) Centres of Excellence. Materials and methods: Cross-sectional data were obtained between December 2020 and April 2021 using an online anonymous structured questionnaire including 26 questions/136 items, that was sent to all ESH Excellence centres. Results: Overall 67 from 187 centres (37.3%) responded and 200 HCPs from 30 countries answered the questionnaire. Participants (60% men) were mainly physicians (91%) and nurses (8%) from University hospitals (77%). Among physicians, 83% had >10 years professional experience. Average time dedicated to discuss medications was 1-5 min in 48% and 6-10 min in 29% of cases. Interviews with patients about adherence were the most frequently used assessment method. Chemical detection of medications in urine was available in 36% of centres. One third of physicians involved their patients regularly in treatment decisions. The most frequent methods to improve adherence included simplification of medication therapy, more frequent visits, and home blood pressure monitoring. Conclusions: The level of implementation of tools to detect and improve adherence in hypertension management by HCPs in ESH excellence centres is low. Structured educational activities focussing on adherence management and access to the newest objective measures to detect non-adherence might improve these deficits.
UR - http://www.scopus.com/inward/record.url?scp=85112683302&partnerID=8YFLogxK
U2 - 10.1080/08037051.2021.1963209
DO - 10.1080/08037051.2021.1963209
M3 - Article
C2 - 34392741
AN - SCOPUS:85112683302
VL - 30
SP - 282
EP - 290
JO - Blood Pressure
JF - Blood Pressure
SN - 0803-7051
IS - 5
ER -